Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
07 jan 2009 - 23:35
Statutaire naam
Crucell N.V.
Titel
Crucell and Wyeth in discussion on a combination of the two companies
Bericht
Leiden, The Netherlands, 7 January 2009 – Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today confirms that it is in friendly discussions with Wyeth that may lead to a combination of the two companies. These discussions are at a preliminary stage and there is no certainty that they will result in a transaction. An update will be provided in due course.
This statement is an announcement as referred to in Section 5:59 paragraph 1 of the Dutch Financial Supervision Act (Wet op het financieel toezicht).
Datum laatste update: 25 december 2025